Timetable

  Thursday, October 17, 2019

  Hall A 
 08:00 – 16:00 Ultrasound Workshop
Supported by Novartis
 16:00 – 16:30 Break
 16:30 – 17:00 Opening Session
17:00 – 17:10 Break
17:10 – 18:10 Industry Symposium:
Re-assessing the ESCEO algorithm for knee OA in the long-term perspective
Supported by Mylan
18:10 Networking Reception

 

  Friday, October 18, 2019

  Hall A
 08:00 – 09:00 Round Table:
Headache for rheumatologists: Arthritis pain and central sensitization syndrome
 09:00 – 10:00 Round Table:
Osteoporosis in rheumatic diseases: A neglected story in rheumatology

 10:00 – 10:20 Coffee Break and Poster Viewing
 10:20 – 11:20 Debate:
Biosimilars or Janus Kinase inhibitors (JAKi) should be the first line treatment of rheumatoid arthritis?

 11:20 – 12:20 Industry Symposium:
12:20 – 13:20 Lunch Break and Poster Viewing
13:20 – 14:20 Round Table:
Which biologics are safe for tuberculosis and/or hepatitis C?

14:20 – 15:20 Debate:
Intraarticular injections of platelet rich plasma for osteoarthritis treatment: What to tell the patient

15:20 – 15:40 Coffee Break and Poster Viewing
15:40 – 16:40 Round Table:
Systemic lupus erythematosus: Biologic or non-biologic treatment?
16:40 – 17:40 Taiwan Rheumatology Association Symposium:
Biosimilars in rheumatology: Perspectives around the world

 

  Saturday, October 19, 2019

  Hall A
 08:00 – 09:00 Consensus:
Cardiovascular risks in inflammatory arthritis: Risk assessment and management in daily practice

09:00 – 10:00 APLAR Session:
Novel approaches for osteoarthritis outcome prediction

 10:00 – 10:20 Coffee Break and Poster Viewing
10:20 – 11:20 Round Table:
Lessons learned from the registries: Did it change practice?

11:20 – 12:20 Session:
Oral Abstracts and Award Presentations

12:20 – 13:20 Lunch Break and Poster Viewing
13:20 – 14:50 Round Table:
Large vessel vasculitis: What are the options for investigation, disease treatment and management?
14:50 – 15:10 Coffee Break and Poster Viewing
15:10 – 16:10 Debate:
Gout and crystal arthropathies: Benign diseases with a potentially deadly outcome?
16:10 – 17:10 Round Table:
The future of rheumatology: Reality and challenges

17:10 – 17:15 Closing Remarks

*Subject to change